FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
On Jun. 16, 2026, the U.S. Food and Drug Administration (FDA) approved another over-the-counter (OTC) intranasal naloxone product,…
-
-
U.S. FDA approved second OTC Naloxone nasal spray product
On Jul. 28, 2023, the U.S. U.S. Food and Drug Administration (FDA) approved RiVive, 3 milligram (mg) naloxone…
